BridgeBio Pharma (BBIO)
(Delayed Data from NSDQ)
$24.88 USD
+0.55 (2.26%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $24.91 +0.03 (0.12%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.40 | -167.77% |
Earnings Summary
For their last quarter, BridgeBio Pharma (BBIO) reported earnings of -$0.96 per share, missing the Zacks Consensus Estimate of -$0.95 per share. This reflects a negative earnings surprise of 1.05%. Look out for BBIO's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.40 per share, reflecting a year-over-year increase of 56.52%.
Earnings History
Price & Consensus
Zacks News for BBIO
Bayer (BAYRY) Banks on Pipeline Progress Amid Challenges
BBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services